Illumina

Medical Equipment
ILMN
$ 243 4.1
Share price
$ 38 bn
Market Cap
$ 48 bn
Enterprise Value

Carbon footprint

0.77 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2020
How is this calculated?
+6.3%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-3.4%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Illumina aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2019


1.5°C
Illumina's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Illumina's GHG emissions (location-based) (Kt of CO2e)
Illumina's Carbon intensity (Tons per 1 USDm)

Illumina's carbon footprint

Illumina reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 37 Kt (+2.2/+6.3% y-o-y). Carbon intensity also grew to 11 t (+1.6/+16% y-o-y).

No public disclosure of Scope 3 emissions has been found for Illumina at the moment.

The company is committed to reducing Scope 1 + 2 by 30% by 2030 from a base year 2019, which translates into the estimated reduction of -1.2 Kt per annum over the period of FY2021 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Illumina aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2023. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.

Company environmental metrics

Show more...